Cancer dormancy: time to explore its clinical relevance
- PMID: 24359585
- PMCID: PMC3979111
- DOI: 10.1186/bcr3590
Cancer dormancy: time to explore its clinical relevance
Abstract
Dormant disseminated cancer cells, arrested and nonproliferating, are "good" cancer cells because there is no need to worry unless they resume growth. The mechanisms by which dormant disseminated cancer cells are put to sleep at distant sites and re-awakened are poorly understood. Moreover, it is not clear whether re-awakened cancer cells have a role in disease courses. Cyrus Ghajar and colleagues identified a mechanism of dormancy and growth resumption that might become important when more closely linked to clinical reality.
Comment on
-
The perivascular niche regulates breast tumour dormancy.Nat Cell Biol. 2013 Jul;15(7):807-17. doi: 10.1038/ncb2767. Epub 2013 Jun 2. Nat Cell Biol. 2013. PMID: 23728425 Free PMC article.
References
-
- Buell JF, Beebe TM, Trofe J, Gross TG, Alloway RR, Hanaway MJ, Woodle ES. Donor transmitted malignancies. Ann Transplant. 2004;15:53–56. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
